Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A (Dysport) for overactive bladder after failure of conservative therapy
2005-004011-30Phase 4Completed
- Sponsor
- Gwent Healthcare NHS Trust
- Start
- Oct 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of botulinum toxin type A in overactive bladder (OAB), sponsored by Gwent Healthcare NHS Trust. Primary endpoint: Efficacy parameters of the study. Started Oct 2005; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on 2005-004011-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004011-30.